<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Hekmat-Based Medicine Approach in Masih Daneshvari Referral Pulmonary Hospital</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>322</FirstPage>
			<LastPage>323</LastPage>
			<ELocationID EIdType="pii">728961</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ali Akbar</FirstName>
					<LastName>Velayati</LastName>
<Affiliation>Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Varahram</LastName>
<Affiliation>Mycobacteriology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8033-1867</Identifier>

</Author>
<Author>
					<FirstName>Elham</FirstName>
					<LastName>Ghazanchaei</LastName>
<Affiliation>Research Department for Hospital Management and Health Policy in Respiratory Diseases,  NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-6048-3396</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>09</Month>
					<Day>11</Day>
				</PubDate>
			</History>
		<Abstract></Abstract>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728961_31b9347bd41fea69a3eb273628a71f0e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The History of Anesthesia and Anesthesiologists in Iran</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>324</FirstPage>
			<LastPage>333</LastPage>
			<ELocationID EIdType="pii">729023</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Salimi</LastName>
<Affiliation>Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-5787-4807</Identifier>

</Author>
<Author>
					<FirstName>Makan</FirstName>
					<LastName>Sadr</LastName>
<Affiliation>Virology Research Center, NRITLD, Shahid Beheshti University of Medical Science, Tehran, Ira</Affiliation>
<Identifier Source="ORCID">0000-0002-8781-8176</Identifier>

</Author>
<Author>
					<FirstName>Babak</FirstName>
					<LastName>Daneshfard</LastName>

						<AffiliationInfo>
						<Affiliation>Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Canadian College of Integrative Medicine (CCIM), Montreal, Quebec, Canada</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Persian Medicine Network (PMN), Universal Scientific Education and Research Network (USERN), Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-6729-9113</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>08</Day>
				</PubDate>
			</History>
		<Abstract>The evolution of anesthesia and anesthesiology represents a pivotal chapter in the history of medical science, significantly enhancing patient care and surgical outcomes. General anesthesia, defined as the deliberate induction of a temporary state of pain relief, muscle paralysis, memory impairment, and unconsciousness, has revolutionized medical procedures by inhibiting the normal functioning of the central nervous system. In Iran, the journey of anesthesiology began with early contributions from ancient scholars and practitioners, whose innovative techniques laid the groundwork for future advancements. The field witnessed significant progress in the mid-20th century, aligning with global developments in medical science. Initially focused on intraoperative care, anesthesiology in Iran expanded to encompass preoperative evaluations, postoperative assessments, and comprehensive patient monitoring, addressing complications related to surgery and anesthesia. In addition to analyzing the evolution of anesthesiology from solely surgical intervention to a broader field encompassing preoperative evaluation, postoperative care, and critical care management, this paper addresses the challenges and opportunities facing anesthesia and anesthesiology in Iran, including the need for wider access to safe and reliable services and the integration of advanced technologies.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Anesthesia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anesthesiology</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anesthesiologist</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">History of Medicine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Iran</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Medical education</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Persia</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_729023_2b46e3ed5a9cd4977a52588672576ef1.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Thymoquinone Targeting T Helper 2 Cytokines in Animal Models of Asthma: A Systematic Review</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>334</FirstPage>
			<LastPage>340</LastPage>
			<ELocationID EIdType="pii">728962</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Hanieh</FirstName>
					<LastName>Tahermohammadi</LastName>
<Affiliation>Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7742-2154</Identifier>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Abdolahinia</LastName>

						<AffiliationInfo>
						<Affiliation>Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Persian Medicine Network (PMN), Universal Scientific Education and Research Network (USERN), Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-8162-4883</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Ali</FirstName>
					<LastName>Tahermohammadi</LastName>
<Affiliation>Department of Radiology, Iran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0009-0001-3863-6739</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Ali</FirstName>
					<LastName>Hojjati Kermani</LastName>
<Affiliation>Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-2364-3696</Identifier>

</Author>
<Author>
					<FirstName>Babak</FirstName>
					<LastName>Daneshfard</LastName>

						<AffiliationInfo>
						<Affiliation>Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Persian Medicine Network (PMN), Universal Scientific Education and Research Network (USERN), Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Canadian College of Integrative Medicine (CCIM), Montreal, Quebec, Canada,</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Mizaj Health Research Institute (MHRI), Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-6729-9113</Identifier>

</Author>
<Author>
					<FirstName>Ali Akbar</FirstName>
					<LastName>Velayati</LastName>
<Affiliation>Mycobacteriology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9398-5838</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>12</Month>
					<Day>30</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Thymoquinone (TQ) is one of the active components of &lt;em&gt;Nigella sativa&lt;/em&gt; L. It has therapeutic properties in allergic diseases, such as the antihistamine effect on the airways of patients with asthma and inhibition of inflammatory changes. This systematic review was conducted to investigate the effect of TQ on T helper 2 (Th2) cytokines, including IL-4, IL-5, and IL-13, in the treatment of animal models of asthma.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;A comprehensive article search was conducted using Web of Science, Scopus, and PubMed to find articles published until 2022 regarding the efficacy of TQ in treating animal models of asthma. We found 399 articles in Scopus, 927 in Web of Science, and 790 in PubMed, from a total number of 2116 articles. After deleting duplicate articles, we read the remaining 1126 titles and abstracts. Finally, 37 articles were selected for full reading. After excluding papers without full text, duplicates, letters, case studies, and those whose topic did not meet the criteria of this study, 8 articles remained. In the manual search, we did not find any deviating articles from the systematic search.
&lt;strong&gt;Results: &lt;/strong&gt;Our results showed that TQ had a significant effect on the reduction of Th2 cytokines, including IL-4, IL-5, and IL-13, in animal models of asthma.
&lt;strong&gt;Conclusion: &lt;/strong&gt;Current evidence shows the anti-inflammatory effects of TQ on Th2 cytokines, but its association with the reduction of Th2 cytokines in animal models of asthma needs further studies.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Asthma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Thymoquinone, Nigella sativa L</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Inflammation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">T helper 2</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728962_59029c626570c8b66b556deadd2286a7.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Sonography Guided Evaluation of Hemodynamic Indices in Critically Ill Patients Suffering from AKI during CRRT</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>341</FirstPage>
			<LastPage>348</LastPage>
			<ELocationID EIdType="pii">728963</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Morteza</FirstName>
					<LastName>Foroumandi</LastName>
<Affiliation>Department of Intensive Care Medicine, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-5921-700X</Identifier>

</Author>
<Author>
					<FirstName>Seyedpouzhia</FirstName>
					<LastName>Shojaei</LastName>
<Affiliation>Department of Critical Care Medicine, Imam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8708-0119</Identifier>

</Author>
<Author>
					<FirstName>Batoul</FirstName>
					<LastName>Khoundabi</LastName>
<Affiliation>Iran Helal Institute of Applied-Science and Technology, Red Crescent Society of Iran, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8558-4735</Identifier>

</Author>
<Author>
					<FirstName>Farin</FirstName>
					<LastName>Rashid Farokhi</LastName>

						<AffiliationInfo>
						<Affiliation>CKD Research Centre, Shahid Beheshti University of Medical Science, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Telemedicine Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Mehrdad</FirstName>
					<LastName>Bakhshayesh Karam</LastName>
<Affiliation>Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-4864-6161</Identifier>

</Author>
<Author>
					<FirstName>Ahsina</FirstName>
					<LastName>Jahan Lopa</LastName>
<Affiliation>MBBS, FICM, ICU in-charge, Department of ICU and Emergency, Shahabuddin Medical College Hospital, Dhaka, Bangladesh</Affiliation>
<Identifier Source="ORCID">0000-0002-5336-4217</Identifier>

</Author>
<Author>
					<FirstName>Hassan</FirstName>
					<LastName>Safdari</LastName>
<Affiliation>Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, Massachusetts, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-8209-0091</Identifier>

</Author>
<Author>
					<FirstName>Ranajit</FirstName>
					<LastName>Chatterjee</LastName>
<Affiliation>MBBS, MRCP, FRCP, EDIC, DA(Gold Medal) FIACM Head Critical Care, Head Accident and Emergency Swami Dayanand Hospital, New Delhi, India</Affiliation>
<Identifier Source="ORCID">0000-0003-2776-7802</Identifier>

</Author>
<Author>
					<FirstName>Seyed MohammadReza</FirstName>
					<LastName>Hashemian</LastName>
<Affiliation>Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-0768-9168</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2021</Year>
					<Month>11</Month>
					<Day>19</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Recent pieces of evidence have shown higher efficacy of continuous renal replacement therapy (CRRT) with regard to improvement of survival in critically ill patients by maintaining hemodynamic stability. The present study aimed to assess hemodynamic conditions before and after CRRT with the point-of-care approach.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;The present interventional before-after study was performed on 20 critically ill patients with unstable hemodynamic status admitted to the ICU at Masih-e-Daneshvari Hospital in Tehran in 2019. They were candidate for CRRT due to acute kidney injury (AKI). The main pointed parameters for assessment before and after CRRT included heart rate, mean arterial pressure (MAP), central vein pressure (CVP), the carotid corrected flow time (FTc), carotid peak systolic velocity (PSV), inferior vena cava collapsibility (cIVC), resistive index (RI), and inferior vena cava (IVC) size and distensibility aided by ultrasonography.
&lt;strong&gt;Results: &lt;/strong&gt;Regarding the changes in ultrasonography parameters after CRRT, except for carotid PSV, heart rate, and carotid area, other parameters showed a significant change. In this regard, IVC size, FTc, MAP, CVP, internal jugular vein (IJV) area, and RI all significantly decreased while IVC distensibility index significantly increased following CRRT. Similar changes were revealed in the subgroup of patients with hypotension, but in another subgroup without hypotension, the decrease in carotid PSV was also meaningful.
&lt;strong&gt;Conclusion: &lt;/strong&gt;Applying CRRT in AKI patients in critically ill situations can effectively balance cardiovascular and hemodynamic parameters and thus lead to more appropriate survival.   </Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Acute renal failure</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Continuous renal replacement therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Medical Intensive Care Unit</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728963_677f5bf57156c8e608a93fd849e3cbe9.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Assessment of Clinical, Histopathologic, and Radiologic Features in Extrapulmonary Tuberculosis Patients</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>349</FirstPage>
			<LastPage>354</LastPage>
			<ELocationID EIdType="pii">728966</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ladan</FirstName>
					<LastName>Kharraz</LastName>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-5156-9905</Identifier>

</Author>
<Author>
					<FirstName>Aida</FirstName>
					<LastName>Bagheri</LastName>
<Affiliation>Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Firouze</FirstName>
					<LastName>Hatami</LastName>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-0450-0961</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Mahdi</FirstName>
					<LastName>Rabiei</LastName>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-9544-2861</Identifier>

</Author>
<Author>
					<FirstName>Farid</FirstName>
					<LastName>Javandoust Gharehbagh</LastName>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-9127-9470</Identifier>

</Author>
<Author>
					<FirstName>Ilad</FirstName>
					<LastName>Alavi Darazam</LastName>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-4440-335X</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>09</Month>
					<Day>10</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Tuberculosis (TB) is clinically divided into two categories: pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB). PTB has many different manifestations, and sometimes the initial diagnosis is challenging and depends on the prevalence of infection as well as the experience and development of local medical centers. Thus, we aimed to review all EPTB patients in our referral center.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;This retrospective study reviewed all confirmed cases of EPTB referred to a referral/general center within the last decade.
&lt;strong&gt;Results: &lt;/strong&gt;This study included&lt;strong&gt; &lt;/strong&gt;68 cases of EPTB. Percentages of males and females were 58.8% and 41.2%, respectively.&lt;strong&gt; &lt;/strong&gt;The majority of EPTB patients were TB meningitis (44.1%), followed by musculoskeletal TB (17.6%).&lt;strong&gt; &lt;/strong&gt;About 8.8% of patients had a positive culture. The acid-fast bacilli test was found to be positive in 19.1% of cases. The mortality rate in this study was 19.1% and the highest rate of mortality was observed in intestinal and mesenteric TB (33.3%).
&lt;strong&gt;Conclusion: &lt;/strong&gt;According to this study, the majority of hospitalized EPTB patients had TB meningitis. The mortality rate in intestinal and mesenteric TB was higher compared to other types of EPTB, probably due to delayed diagnosis. In the current study, Positive results for smears and cultures were also low.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Extrapulmonary tuberculosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Mortality</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">TB</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728966_151d85905684370a29afafd4b03fb204.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Optimized Conservative Surgical Treatment of Pulmonary Hydatid Cyst: A Retrospective Observational Cohort Study</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>355</FirstPage>
			<LastPage>363</LastPage>
			<ELocationID EIdType="pii">728969</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Abdoulhossein</FirstName>
					<LastName>Davoodabadi</LastName>
<Affiliation>Department of General and Thoracic Surgery, Kashan University of Medical Sciences, Kashan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Najjarian</LastName>
<Affiliation>Departments of General Surgery, Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad Java</FirstName>
					<LastName>Azadchehr</LastName>
<Affiliation>Department of Biostatistics and Epidemiology, Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Esmail</FirstName>
					<LastName>Abdorrahhmkashi</LastName>
<Affiliation>Department of General and Thoracic Surgery, Kashan University of Medical Sciences, Kashan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hassan</FirstName>
					<LastName>Davoodabadi</LastName>
<Affiliation>Departments of Surgery, Qom University of Medical Sciences, Qom, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Aboulhassan</FirstName>
					<LastName>Alijanpour</LastName>
<Affiliation>Departments of Surgery, Babol  University of Medical Sciences, Sari</Affiliation>

</Author>
<Author>
					<FirstName>Babak</FirstName>
					<LastName>Haghpanah</LastName>
<Affiliation>Departments of Surgery, Kashan University of Medical Sciences, Kashan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>06</Month>
					<Day>30</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;There are some controversies on surgical options for pulmonary hydatid cysts. We analyzed our experience in lung tissue preservation during the surgical treatment and optimal surgical options.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;This observational cohort analysis was conducted from July 2008 to July 2022. The Age, sex, clinical manifestation, recurrent rate, hospital length of stay, postoperative complications, and long-term results in each group were assessed. The American Society of Anesthesiologists Physical Status, Charlson Co-Morbidity Index (CCI), Complexity of surgery, and Clavien-Dindo score were also determined.
&lt;strong&gt;Results: &lt;/strong&gt;Out of 138 patients, 81case (53.5%) had intact cysts (G1), and the rest were infected cysts which in turn were subdivided into early infected (G2) and cavity suppurated=28 cases (18.4%) as (G3). Group G3 required special attention because the pericyst surface was severely inflamed, dirty, and had pus, so they were subdivided into 3 distinctive groups including G3a, undergone cystectomy, bronchial opening closure alone, G3b group, undergone cystectomy, capitonnage+bronchial opening closure and G3c group, in which pericystectomy also added to previously mentioned procedures. Major complications in the subgroups of G3a were 2 patients and G3b 3 patients, but in the subgroup of G3c, no considerable complications were seen.
Cystectomy, closure of major bronchial opening, and capitonnage were done in intact, and early infected cysts. The results of both were the same, with no considerable major complication.
&lt;strong&gt;Conclusion: &lt;/strong&gt;Capitonnage significantly decreased the complication rate. The optimized approach in both G1 and G2 was: cystectomy, closure of major bronchial opening, and capitonnage. In G3, bronchial opening closure, pericystectomy, and capitonnage were the preferred procedures.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Albendazole</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Capitonnage</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Endobronchial rupture</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hydatid cyst of lung</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pericystectomy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728969_5f349cd8be9f05201c5d863358e71c90.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Clinical Symptoms and Echocardiographic Markers Regarding the Severity of Embolism in Patients with Acute Pulmonary Embolism</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>364</FirstPage>
			<LastPage>370</LastPage>
			<ELocationID EIdType="pii">728970</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Shahabaddin</FirstName>
					<LastName>Sorouri</LastName>
<Affiliation>Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-4847-557X</Identifier>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Naseri</LastName>
<Affiliation>Department of Pediatrics, Mashhad University of Medical Sciences, Mashhad, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sepideh</FirstName>
					<LastName>Hejazi</LastName>
<Affiliation>Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>10</Month>
					<Day>19</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Echocardiography can be used for risk stratification in patients with acute pulmonary embolism (PE). While the severity of PE has been assessed through laboratory criteria in most studies, the Pulmonary Embolism Severity Index (PESI) scoring system was used in this study to evaluate the severity of echocardiographic criteria in acute PE patients.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;All PE patients admitted to Ghaem Hospital in Mashhad between 2021-2022 were included in the study. Clinical symptoms and echocardiographic markers were checked and recorded when the patients entered the study. Data were analyzed in SPSS version 24 at a significance level of 0.05 using the Chi-square test and t-test.
&lt;strong&gt;Results: &lt;/strong&gt;Of 40 patients, 80% were at a high risk of PESI. The most common clinical symptoms were dyspnea (97.5%) and pleuritic chest pain (75%). Right ventricle (RV) size enlargement and its dysfunction were recorded in 57.5% of patients. The average age of patients in the high-risk group was significantly (p-value: 0.001) higher than the low-risk group. There was a significant correlation between MID-right ventricle and pulmonary artery pressure with the severity of embolism, so that mid-right ventricle and pulmonary artery pressure in the high-risk group were significantly higher (p-value: 0.000) than in the low-risk group. Also, the severity of PE was significantly related to RV size (P = 0.026) and function (P = 0.038).
&lt;strong&gt;Conclusion: &lt;/strong&gt;RV size, function, and dilatation, and pulmonary artery pressure variated significantly in different severities of PE.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Acute pulmonary embolism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Echocardiography</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Clinical Symptoms</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728970_ea5811d315aeccc31a0b95a544c29d7e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Heart Rate Variability in Obstructive Sleep Apnea: Association with Excessive Daytime Sleepiness and Cardiovascular Risk</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>371</FirstPage>
			<LastPage>375</LastPage>
			<ELocationID EIdType="pii">728971</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Besharat</FirstName>
					<LastName>Rahimi</LastName>
<Affiliation>Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-0193-3243</Identifier>

</Author>
<Author>
					<FirstName>Niloofar</FirstName>
					<LastName>Khoshnam Rad</LastName>
<Affiliation>Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-6700-3570</Identifier>

</Author>
<Author>
					<FirstName>Tayebe</FirstName>
					<LastName>Mohammad Alizade</LastName>
<Affiliation>Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0009-0004-3534-3887</Identifier>

</Author>
<Author>
					<FirstName>Somaye</FirstName>
					<LastName>Mohammadi</LastName>
<Affiliation>Department of Cardiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0009-0001-2045-5948</Identifier>

</Author>
<Author>
					<FirstName>Shahram</FirstName>
					<LastName>Firoozbakhsh</LastName>
<Affiliation>Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0009-0008-3108-5795</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>10</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Obstructive sleep apnea (OSA) is associated with increased vagal activity, sympathetic nervous system activation, and cardiovascular complications. Excessive daytime sleepiness (EDS) in OSA patients is a predictor of cardiovascular and all-cause mortality. Heart rate variability (HRV) can be used to assess cardiac autonomic modulation, which is affected by OSA. This study aimed to evaluate the relationship between HRV and daily sleepiness in OSA patients based on the excessive sleep scale (ESS) scores.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;The study included 70 patients with OSA, divided into two groups: those with EDS (ESS ≥ 11) and those without sleepiness (ESS &lt; 11). Time and frequency domain parameters were evaluated. The results were compared and analyzed between the two groups.
&lt;strong&gt;Results: &lt;/strong&gt;Patients with OSA and EDS had higher cardiovascular risk, as indicated by different HRV parameters (higher low-frequency parameter and higher time domain parameters), compared to non-sleepy OSA patients. A significant positive correlation was found between ODI and AHI with VLF, and significantly higher LF and VLF in EDS patients.
&lt;strong&gt;Conclusion: &lt;/strong&gt;OSA patients with EDS had higher cardiovascular risk, as indicated by different HRV parameters, compared to non-sleepy OSA patients. A significant positive correlation was found between ODI and AHI with VLF, and significantly higher LF and VLF in EDS patients. Further studies are needed to better understand the relationship between HRV and daily sleepiness in patients with OSA.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">obstructive sleep apnea</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Heart rate variability</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Excessive Daytime Sleepiness</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728971_c157948f529ff2def21d6fdd72e479dd.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Predictors of Quality of Life in Patients with Asthma in Ahvaz, Iran</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>376</FirstPage>
			<LastPage>391</LastPage>
			<ELocationID EIdType="pii">728973</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ahmad</FirstName>
					<LastName>Tahmasebi Ghorrabi</LastName>

						<AffiliationInfo>
						<Affiliation>School of Health Management &amp; Information Sciences, Iran University of Medical Sciences, Tehran, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-0115-3688</Identifier>

</Author>
<Author>
					<FirstName>Hanieh</FirstName>
					<LastName>Raji</LastName>
<Affiliation>Department of Internal Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-0495-0807</Identifier>

</Author>
<Author>
					<FirstName>Amin</FirstName>
					<LastName>Torabipour</LastName>

						<AffiliationInfo>
						<Affiliation>Nursing Care Research Center in Chronic Diseases, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Healthcare Services Management, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-8937-8004</Identifier>

</Author>
<Author>
					<FirstName>Seydeh Maryam</FirstName>
					<LastName>Mousavi</LastName>
<Affiliation>School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Zahara</FirstName>
					<LastName>Oraman</LastName>
<Affiliation>School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0009-0005-5821-820x</Identifier>

</Author>
<Author>
					<FirstName>Parisa</FirstName>
					<LastName>Badiei Nasab</LastName>
<Affiliation>School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0009-0006-0605-7552</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Hosein</FirstName>
					<LastName>Haghighizadeh</LastName>
<Affiliation>Department of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-4197-0199</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>11</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Asthma impacts the quality of life (QOL) of patients and their families. The magnitude of this morbidity is influenced by several factors, including age, disease duration, and others. This study was conducted to determine the predictors of quality of life in patients with asthma in Ahvaz, Iran.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;This cross-sectional study was conducted among patients referred to the pulmonary clinics of Imam Khomeini and Golestan hospitals in Ahvaz in 2022. The quality of life was assessed using the SF-36v2 questionnaire. The effect of socio-demographic characteristics on quality-of-life scores was examined by t-test, one-way variance (ANOVA), Pearson&#039;s correlation coefficient, and regression models.
&lt;strong&gt;Results: &lt;/strong&gt;From a total of 204 studied asthmatic patients, the average age of patients was 43.22±15.17 years. The average QOL in patients was 57.69±22.97. Physical role and social functioning had the lowest and highest mean scores among SF-36 dimensions, respectively. A significant difference was observed between the average QOL score and the variables of age, gender, education level, employment status, illness costs, illness severity, daily exercise, and number of visits (P&lt;0.05). Most clinical, socio-demographic, and economic variables were predictors of SF-36, PCS, MCS, and QOL dimensions (P&lt;0.05).
&lt;strong&gt;Conclusion: &lt;/strong&gt;This study showed that the quality of life in asthmatic patients is affected by the severity of the disease, number of visits, age, sex, and education. By performing appropriate interventions on social and economic factors, the quality of life of asthmatic patients can be improved.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Risk Factors</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Quality of Life</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Asthma</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728973_414a3fdd93758c322085227f8e9b778c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Effect of Chest Physiotherapy on the Clinical Outcomes of COVID-19 Patients</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>392</FirstPage>
			<LastPage>402</LastPage>
			<ELocationID EIdType="pii">728974</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Reza</FirstName>
					<LastName>Moradi-Azhgil</LastName>
<Affiliation>Department of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Neda</FirstName>
					<LastName>Sayadi</LastName>
<Affiliation>Department of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-8537-3185</Identifier>

</Author>
<Author>
					<FirstName>Shayesteh</FirstName>
					<LastName>Haghighi</LastName>
<Affiliation>Department of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2860-6410</Identifier>

</Author>
<Author>
					<FirstName>Parya</FirstName>
					<LastName>Moradi</LastName>
<Affiliation>Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
<Identifier Source="ORCID">0009-0002-8835-4729</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>11</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;The novel coronavirus 2019 primarily affects the respiratory system and may lead to respiratory failure and the need for intubation. This study aimed to investigate the effect of chest physiotherapy on the clinical outcomes of patients with COVID-19.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;This randomized clinical trial was performed in 2022-2023. The research population included 58 patients with COVID-19 who were hospitalized at Izeh Shohada Hospital, Khuzestan. Patients in the control group received routine care, which included the use of supportive drugs based on the doctor&#039;s opinion, oxygen therapy, and nutritional support. The intervention group received chest physiotherapy and breathing exercises for six days. At the end of the third and sixth days, the patients of both groups were evaluated in terms of lung function, respiratory gases, and the length of hospital stay. Moreover, the need for intubation was recorded during study time. Data analysis was done using SPSS version 23 software.
&lt;strong&gt;Results: &lt;/strong&gt;In the intervention group, a significant improvement was observed in FVC (P&lt;0.01), FEV&lt;sub&gt;1&lt;/sub&gt;(P&lt;0.01), FEV&lt;sub&gt;1&lt;/sub&gt;/FVC ratio (P&lt;0.01), PaO&lt;sub&gt;2 &lt;/sub&gt;(P&lt;0.01), PaCO&lt;sub&gt;2 &lt;/sub&gt;(P&lt;0.01), and SPO&lt;sub&gt;2&lt;/sub&gt; (P&lt;0.01) as well as the length of hospital stay (P&lt;0.01) after the intervention. However, no significant difference was observed in the PaO2/FiO&lt;sub&gt;2 &lt;/sub&gt;ratio (P&gt;0.05) and the need for intubation (P&gt;0.05).
&lt;strong&gt;Conclusion: &lt;/strong&gt;The results showed that in the new crisis resulting from COVID-19, chest physiotherapy and respiratory exercises could be used as a helpful method in improving lung function, respiratory gases, and reducing the hospital stay in COVID-19 patients.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">COVID-19</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Respiratory system</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Intubation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hospital stay</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Respiratory gases</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chest physiotherapy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728974_6ed4f73374f82d04db1ce68fab40eecd.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Effectiveness of Cognitive Behavioral Therapy and Motivational Interviewing on Perceived Stress and ICU Stay in Neurosurgical Patients: A Quasi-Experimental Study</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>403</FirstPage>
			<LastPage>408</LastPage>
			<ELocationID EIdType="pii">728975</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>َAli</FirstName>
					<LastName>Solgi</LastName>
<Affiliation>PhD Student of Health Psychology, Department of Psychology, Emirate Branch, Islamic Azad University, Dubai, UAE</Affiliation>
<Identifier Source="ORCID">0000-0001-8577-2306</Identifier>

</Author>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Zali</LastName>
<Affiliation>Department of Neurosurgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-2298-2290</Identifier>

</Author>
<Author>
					<FirstName>Hassan</FirstName>
					<LastName>Ahadi</LastName>
<Affiliation>Department of Psychology, Allameh Tabataba'i University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Farhad</FirstName>
					<LastName>Jomehri</LastName>
<Affiliation>Department of Psychology, Allameh Tabataba'i University, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>12</Month>
					<Day>30</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;Neurosurgical operations, especially for brain tumors, are among the most stressful medical procedures due to diagnostic uncertainties, high morbidity, and long post-operative recovery, including ICU admission. Stress management interventions may improve outcomes. This study aimed to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Motivational Interviewing (MI) in reducing perceived pre- and post-operative stress and ICU stay in patients undergoing brain surgery.
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;In a quasi-experimental design, 80 neurosurgical candidates admitted to Shohadaye Tajrish Hospital during 2020–2022 were randomly assigned to intervention and control groups. The intervention group received 15 CBT-based sessions focused on stress management and cognitive restructuring. Stress levels were assessed using Cohen’s Perceived Stress Scale (1983), and CBT protocols followed Miller (2003). Data were analyzed with SPSS using chi-square tests, independent and paired t-tests, and ANCOVA.
&lt;strong&gt;Results: &lt;/strong&gt;Patients who received CBT demonstrated significantly lower perceived stress scores postoperatively (p&lt;0.001) and had a shorter ICU stay by an average of 3.2 days (p=0.049). No significant demographic differences were observed between groups.
&lt;strong&gt;Conclusion: &lt;/strong&gt;CBT significantly reduces perioperative stress and ICU duration in neurosurgical patients. Integrating psychological interventions like CBT into preoperative care protocols may enhance recovery, reduce complications, and lower healthcare costs.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Neurosurgery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ICU</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Perceived stress</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cognitive Behavioral Therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Motivational interviewing</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728975_7608a573ddb547a48d79a04651e0a8f9.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Methylprednisolone-Induced Hyperlactatemia: A Case Report</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>409</FirstPage>
			<LastPage>412</LastPage>
			<ELocationID EIdType="pii">728976</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sarah</FirstName>
					<LastName>Saenz</LastName>
<Affiliation>Department of Anesthesiology, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0009-0009-8479-4373</Identifier>

</Author>
<Author>
					<FirstName>Anila</FirstName>
					<LastName>Bhatti</LastName>
<Affiliation>Department of Anesthesiology, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0009-0008-5471-6123</Identifier>

</Author>
<Author>
					<FirstName>Aaron</FirstName>
					<LastName>Beck</LastName>
<Affiliation>Department of Orthopedic Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-4847-6900</Identifier>

</Author>
<Author>
					<FirstName>Micah T.</FirstName>
					<LastName>Long</LastName>
<Affiliation>Department of Anesthesiology, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-7297-5304</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>07</Month>
					<Day>23</Day>
				</PubDate>
			</History>
		<Abstract>Lactic acidosis is commonly encountered in critical care and can be a harbinger of life-threatening conditions and end-organ ischemia. Importantly, however, other etiologies of lactic acidosis exist. We review the first case of methylprednisolone-induced lactic acidosis in a previously healthy patient who suffered from traumatic spinal cord injury (SCI). A 19-year-old female presented to a level 1 trauma center after a fall resulted in lower extremity paralysis. After imaging revealed a chance fracture dislocation of T7-8 along with spinal cord compromise and swelling, the patient underwent emergent T5-T11 instrumented fusion. Postoperatively, she was given high-dose methylprednisolone in hopes of improving neurologic outcome; soon after administration, she developed lactic acidosis. After workup ruled out hypoperfusion and type A lactic acidosis, we determined that methylprednisolone likely induced non-ischemic, type B, lactic acidosis. The lactate quickly returned to baseline after steroid discontinuation. It is important for clinicians to consider type B lactic acidosis in the ICU in patients with persistent lactic acidosis after tissue hypoperfusion has been ruled out.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Resuscitation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lactic acidosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Steroids</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Spinal Cord Injury</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728976_d87bce0e6d18c90bedcbdd275258bf3c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>A Case of Pneumothorax Following Radiation Therapy for Small Cell Lung Cancer in a Patient with Scleroderma-ILD</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>413</FirstPage>
			<LastPage>416</LastPage>
			<ELocationID EIdType="pii">728977</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Fatih</FirstName>
					<LastName>Uzer</LastName>
<Affiliation>Department of Respiratory Diseases, Akdeniz University, Antalya, Türkiye</Affiliation>
<Identifier Source="ORCID">0000-0001-9318-0458</Identifier>

</Author>
<Author>
					<FirstName>Aykut</FirstName>
					<LastName>Cilli</LastName>
<Affiliation>Department of Respiratory Diseases, Akdeniz University, Antalya, Türkiye</Affiliation>
<Identifier Source="ORCID">0000-0001-9985-3502</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>02</Day>
				</PubDate>
			</History>
		<Abstract>Connective tissue diseases, particularly scleroderma, pose a heightened risk for the development of malignancies such as breast and lung cancer. Stereotactic Body Radiation Therapy (SBRT) has emerged as an effective treatment modality for various cancers, including lung and breast cancers, due to its curative potential, especially for localized extracranial tumors. A 69-year-old patient with a 30-pack-year smoking history presented with shortness of breath and bilateral diffuse rales on chest auscultation during the outpatient clinic visit. Notably, the patient had not received scleroderma treatment for a year at the time of radiation therapy. Despite the recognized sensitivity of the lungs to radiotherapy, the occurrence of pneumothorax and pneumomediastinum following SBRT in this case raises concerns about the potential complications in scleroderma-ILD patients with lung cancer.
This report underscores the need for comprehensive risk assessment and careful consideration of alternative treatment strategies for lung cancer in scleroderma patients, particularly those with pre-existing lung involvement. Further research is warranted to elucidate the mechanisms and risk factors associated with complications following radiotherapy in this patient population, guiding clinicians in optimizing therapeutic approaches for improved outcomes.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Lung cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SBRT</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Scleroderma-ILD</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pneumothorax</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728977_c92680713c37470de3c3aaf91911dfa1.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Hodgkin’s Lymphoma in a 34-Year-Old Patient with Digital Clubbing: A Case Report</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>417</FirstPage>
			<LastPage>420</LastPage>
			<ELocationID EIdType="pii">728979</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Pouyan</FirstName>
					<LastName>Ebrahimi</LastName>
<Affiliation>Student Research Committee, Babol University of Medical Sciences, Babol, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2654-2169</Identifier>

</Author>
<Author>
					<FirstName>Jalal</FirstName>
					<LastName>Heshmatnia</LastName>
<Affiliation>Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-2966-4380</Identifier>

</Author>
<Author>
					<FirstName>Amirmorteza</FirstName>
					<LastName>Solemanijoniani</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Internal Medicine, School of Medicine, Arak University of Medical Sciences, Arak, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Clinical Research Development Unit, Amiralmomenin Hospital, Arak University of Medical Sciences, Arak, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-0236-8258</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>01</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background: &lt;/strong&gt;This is a rare condition, especially in adults, where digital clubbing presents as the initial manifestation of lymphoma. Here, we report a case of intrathoracic Hodgkin&#039;s disease (HD) with digital clubbing.
&lt;strong&gt;Case presentation:&lt;/strong&gt; A 34-year-old female presented with B symptoms and a history of dyspnea. She did not take any particular medicine and had no history of any specific disease in herself or her family. In the examination, the patient has digital clubbing in the fingers and toes, which is painless. He also had decreased respiratory sounds and dullness in the right lung. After a CT scan and observation of consolidation and effusion, we performed a bronchoscopy on the patient. Finally, with the diagnosis of Hodgkin&#039;s lymphoma in the pathological reports, he was subjected to appropriate treatment measures.
&lt;strong&gt;Conclusion: &lt;/strong&gt;A precise examination and paraclinical assistance are needed to rule out intrathoracic malignancies in patients with digital clubbing.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Hodgkin Disease</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Osteoarthropathy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Digital clubbing</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Adults</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728979_b5276de556e738e3291bed4491724612.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>A 15-Year-Old Girl with Chronic Cough and a History of Asthma Treatment</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>421</FirstPage>
			<LastPage>422</LastPage>
			<ELocationID EIdType="pii">728980</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Hassanzad</LastName>
<Affiliation>Pediatric Respiratory Diseases Research Center (PRDRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7164-0599</Identifier>

</Author>
<Author>
					<FirstName>Korosh</FirstName>
					<LastName>Fakhimi Derakhshan</LastName>
<Affiliation>Pediatric Disease Research Center, Guilan University of Medical Sciences, Rasht, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8294-9399</Identifier>

</Author>
<Author>
					<FirstName>Ali Akbar</FirstName>
					<LastName>Velayati</LastName>
<Affiliation>Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>07</Month>
					<Day>12</Day>
				</PubDate>
			</History>
		<Abstract>A 15-year-old girl with wet coughing, occasional fever, nausea, and weight loss came to Masih Daneshvari Hospital. The patient has had dry coughing and wheezing in the last 2 years and was treated for asthma with short-acting beta-2 agonist and inhaler corticosteroids; however, coughs have not been treated completely. Moreover, overnight sweating, loss of appetite, and 10 kg weight loss have been added to the patient&#039;s symptoms since the previous year. On the admission day, the patient had a temperature of 38.2˚c, blood pressure of 95/65 mmHg, heart rate of 110 b/s, respiratory rate of 28, and O&lt;sub&gt;2&lt;/sub&gt; saturation of 94% at room temperature. In the lung’s auscultation, the respiratory sound was decreased on the right side and normal on the left side. The results of the patient&#039;s laboratory tests were as follows: WBC: 13200 (neutrophils: 79%, lymphocytes: 12%), Hemoglobin: 4.7, ESR: 76, ACE: 21, IgG: 13, IgA: 4, IgM: 1, IgE: 500, and Anti-HIV antibody: non-reactive; besides, the liver tests were normal. Radiology and CT scans are shown in the following (Figure 1 A,B).</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Pulmonary</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">tuberculosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">mycobacterium</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728980_0c3c4f746f7c3a5562820d17971f7880.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
